Considering HUMIRA for Psoriasis
If your moderate to severe chronic plaque psoriasis is impacting the way you live, HUMIRA may help.
HUMIRA and Psoriasis
If you have Psoriasis, you will get a personalised treatment plan that takes into account your overall medical condition, age, lifestyle, severity, duration of the Psoriasis and expectations of treatment. A wide variety of treatments are available and may be used in combination.
If topical treatments are not enough, there are other treatments that have been proven effective in treating moderate to severe chronic plaque psoriasis such as:
- Phototherapy treatments
- Systemic treatments (like methotrexate and retinoids, and biologics such as HUMIRA).
Based on clinical trials in adults treated with HUMIRA, it is expected 7 out of 10 adults with moderate to severe plaque Psoriasis can expect a 75% reduction in skin symptoms (severity and/or extent) after just four months§ and in some patients as early as 4 weeks.§ Your dermatologist will be able to assess your response to treatment.
Actual clinical trial patient of a patient that experienced a PASI 75 response
75% reduction in Psoriasis skin symptoms (severity and extent) = PASI 75 response.
Humira for Psoriasis in New Zealand
HUMIRA is known as a biologic and works differently to conventional systemic treatments because it works by identifying and blocking a specific source of inflammation that contributes to Psoriasis symptoms.
HUMIRA is only available on prescription, so if you have moderate to severe chronic plaque Psoriasis and are still experiencing symptoms despite your current treatment, ask your dermatologist to see if HUMIRA is right for you.
The government medicine funding agency, PHARMAC, fully subsidises HUMIRA if your Psoriasis has not fully responded to other medicines prescribed by a specialist, and you meet other criteria required by PHARMAC. Your specialist will discuss whether HUMIRA is right for you, and whether you may qualify for PHARMAC funded treatment. Usual doctor’s consultation fees, and pharmacy prescription charges remain payable by you.
In New Zealand, dermatologists have been able to prescribe HUMIRA since 2009 so there is over eight years’ experience in New Zealand with prescribing HUMIRA for moderate to severe Psoriasis.
In 2019, a New Zealand study call Vitality aimed to look at the effects of HUMIRA on health and disability wellbeing outcomes in patients with Crohn’s disease, rheumatoid arthritis or psoriasis treated in routine clinical practice in New Zealand. Over 160 patients with these conditions were enrolled. The primary measure evaluated was the WHODAS 2.0 (World Health Organization Disability Assessment Schedule), a disability assessment measure developed by the World Health Organisation. Further validated scores looking at factors such as work productivity, mental distress and others were also studied. The study researchers concluded that 6 months treatment with HUMIRA significantly^ improved health and disability in New Zealand patients with Crohn’s disease, rheumatoid arthritis and psoriasis.
^ Change in total WHODAS 2.0 score at 6 months vs baseline. p<0.001
Find out more from our list of useful resources about Psoriasis that has been collated from New Zealand and overseas.
When should I expect to see and feel a difference?
HUMIRA can act quickly; most Psoriasis patients can expect to see improvement in their symptoms within 4 months and in some cases as early as 4 weeks.§ It is possible that no effect is seen after HUMIRA treatment. Discuss your expectations with your doctor. You’ll need to be patient and stay on track with your dosing schedule as advised by your doctor.
Will HUMIRA cure my disease?
Unfortunately, currently there are no treatments available that can cure Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, polyarticular Juvenile Idiopathic Arthritis, Crohn’s Disease, or Psoriasis. HUMIRA will not cure your condition but can help with your symptoms.
Talk with your doctor
We’ve put together a checklist that you can take along to your dermatologist visit to discuss symptoms and treatment options.